Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.24.59 (
MIP
)
4,906
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A biomimetic potentiometric sensor for the specific recognition of
methylphosphonic acid
(
MPA
), the degradation product of nerve agents sarin, soman, VX, etc., was designed. This involves the preparation of
MPA
imprinted polymer particles and removal of the template by soxhlet extraction. Subsequently, the leached
MIP
particles were dispersed in 2-nitrophenyloctyl ether (plasticizer) and embedded in polyvinyl chloride matrix. The sensor responds to
MPA
in the concentration range 5x10(-8) to 1x10(-4) and 1x10(-3) to 1x10(-1)M with a detection limit of 5x10(-8)M. The selectivity of the sensor has been tested with respect to chemical analogues such as phosphoric acid, sodium dihydrogen phosphate, organophosphorous pesticide and triazine herbicides. The utility of the sensor was tested for field monitoring of
MPA
in spiked ground water.
...
PMID:Molecularly imprinted polymer-based potentiometric sensor for degradation product of chemical warfare agents. Part I. Methylphosphonic acid. 1907 51
